Donald P. Lesslie

836 total citations
11 papers, 687 citations indexed

About

Donald P. Lesslie is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Donald P. Lesslie has authored 11 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Hematology. Recurrent topics in Donald P. Lesslie's work include Chronic Myeloid Leukemia Treatments (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Donald P. Lesslie is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Donald P. Lesslie collaborates with scholars based in United States and Spain. Donald P. Lesslie's co-authors include Gary E. Gallick, Justin M. Summy, Nila U. Parikh, José G. Treviño, Cheryl H. Baker, Lee M. Ellis, James L. Abbruzzese, Tomi K. Sawyer, William C. Shakespeare and David S. Hong and has published in prestigious journals such as Cancer Research, American Journal Of Pathology and British Journal of Cancer.

In The Last Decade

Donald P. Lesslie

11 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donald P. Lesslie United States	8	397	353	125	96	87	11	687
Sujatha Jagadeeswaran United States	12	465 1.2×	360 1.0×	197 1.6×	50 0.5×	169 1.9×	16	973
David Cervi United States	13	554 1.4×	377 1.1×	226 1.8×	281 2.9×	104 1.2×	21	948
Enrique Alvarez Sotomayor United States	7	411 1.0×	220 0.6×	289 2.3×	45 0.5×	78 0.9×	9	590
Paraskevi Alexandrou Greece	18	497 1.3×	390 1.1×	280 2.2×	28 0.3×	82 0.9×	43	922
Peng-Chan Lin Taiwan	15	204 0.5×	245 0.7×	130 1.0×	49 0.5×	57 0.7×	30	540
Luigi Manenti United States	10	332 0.8×	470 1.3×	171 1.4×	32 0.3×	115 1.3×	20	886
María J. García‐Barchino Spain	9	237 0.6×	290 0.8×	49 0.4×	41 0.4×	48 0.6×	10	508
Elena D’Aiuto Italy	10	353 0.9×	277 0.8×	101 0.8×	22 0.2×	152 1.7×	10	650
Joanna W. Ho Hong Kong	15	638 1.6×	283 0.8×	281 2.2×	68 0.7×	60 0.7×	16	1.1k
Maozhen Tian United States	8	540 1.4×	364 1.0×	179 1.4×	17 0.2×	80 0.9×	8	760

Countries citing papers authored by Donald P. Lesslie

Since Specialization

Citations

This map shows the geographic impact of Donald P. Lesslie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald P. Lesslie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald P. Lesslie more than expected).

Fields of papers citing papers by Donald P. Lesslie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald P. Lesslie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald P. Lesslie. The network helps show where Donald P. Lesslie may publish in the future.

Co-authorship network of co-authors of Donald P. Lesslie

This figure shows the co-authorship network connecting the top 25 collaborators of Donald P. Lesslie. A scholar is included among the top collaborators of Donald P. Lesslie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald P. Lesslie. Donald P. Lesslie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Putnam, Luke R., Zeinab M. Alawadi, Jason M. Etchegaray, et al.. (2016). How Should Surgical Residents Be Educated About Patient Safety: A Pilot Randomized Controlled Trial. Journal of surgical education. 73(4). 660–667. 12 indexed citations

Kopetz, Scott, Donald P. Lesslie, Serk In Park, et al.. (2009). Synergistic Activity of the Src Family Kinase Inhibitor Dasatinib and Oxaliplatin in Colon Carcinoma Cells Is Mediated by Oxidative Stress. Cancer Research. 69(9). 3842–3849. 127 indexed citations

Lesslie, Donald P., Nila U. Parikh, Ami N. Shah, et al.. (2006). Combined activity of dasatinib (BMS-354825) and oxaliplatin in an orthotopic model of metastatic colorectal carcinoma. Cancer Research. 66. 1114–1114. 4 indexed citations

Lesslie, Donald P., Justin M. Summy, Nila U. Parikh, et al.. (2006). Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases. British Journal of Cancer. 94(11). 1710–1717. 101 indexed citations

Treviño, José G., Michael J. Gray, Steffan T. Nawrocki, et al.. (2006). Src activation of Stat3 is an independent requirement from NF-κB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells. Angiogenesis. 9(2). 101–110. 42 indexed citations

Treviño, José G., Justin M. Summy, Donald P. Lesslie, et al.. (2006). Inhibition of Src Expression and Activity Inhibits Tumor Progression and Metastasis of Human Pancreatic Adenocarcinoma Cells in an Orthotopic Nude Mouse Model. American Journal Of Pathology. 168(3). 962–972. 165 indexed citations

Lesslie, Donald P., Nila U. Parikh, Ami N. Shah, et al.. (2006). Dasatinib (BMS-354825), a dual SRC/ABL tyrosine kinase inhibitor, inhibits tumor formation and prevents malignant ascites in a murine model of peritoneal carcinomatosis. Journal of the American College of Surgeons. 203(3). S87–S88. 1 indexed citations

Bauer, Todd W., Ray Somcio, Fan Fan, et al.. (2006). Regulatory role of c-Met in insulin-like growth factor-I receptor–mediated migration and invasion of human pancreatic carcinoma cells. Molecular Cancer Therapeutics. 5(7). 1676–1682. 83 indexed citations

Summy, Justin M., José G. Treviño, Donald P. Lesslie, et al.. (2005). AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes. Molecular Cancer Therapeutics. 4(12). 1900–1911. 73 indexed citations

10.

Treviño, José G., Justin M. Summy, Michael J. Gray, et al.. (2005). Expression and Activity of Src Regulate Interleukin-8 Expression in Pancreatic Adenocarcinoma Cells: Implications for Angiogenesis. Cancer Research. 65(16). 7214–7222. 73 indexed citations

11.

Lesslie, Donald P. & Gary E. Gallick. (2005). Src Family Kinases as Regulators of Angiogenesis: Therapeutic Implications. Current Cancer Therapy Reviews. 1(1). 45–50. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact